Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Features

Practice Tip: The Use of Cy Pres Funds in Class Action Litigation Image

Practice Tip: The Use of Cy Pres Funds in Class Action Litigation

Ronald J. Levine & Yael Weitz

Any product liability litigator who prosecutes or defends class actions should be familiar with the concept of "cy pres" ' which has been the subject of significant recent attention by the courts and commentators.

Features

Air Bag Warning Claim Preempted Image

Air Bag Warning Claim Preempted

Michael Hoenig

Two recent cases highlight issues of importance to practitioners. One case dealt with preemption; the other with discovery sanctions.

July issue in PDF format Image

July issue in PDF format

ALM Staff & Law Journal Newsletters

…

Features

Case Briefs Image

Case Briefs

ALM Staff & Law Journal Newsletters

Highlights of the latest insurance cases from around the country.

Features

What's Reasonable to Expect? Image

What's Reasonable to Expect?

Lucas M. Blower

A number of jurisdictions have adopted one version or another of the reasonable expectations doctrine.

Features

In the Courts Image

In the Courts

ALM Staff & Law Journal Newsletters

In-depth analysis of recent key cases.

Features

Business Crimes Hotline Image

Business Crimes Hotline

ALM Staff & Law Journal Newsletters

Recent rulings of interest.

The Limitations of Liability Coverage Under 'Designated Premises' Policies Image

The Limitations of Liability Coverage Under 'Designated Premises' Policies

Jonathan H. Pittman & Elaine A. Panagakos

Where CGL coverage is not available, some policyholders have attempted to obtain general liability coverage under policies that provide a more limited coverage, namely policies that provide coverage for bodily injury or property damage liability arising out of the ownership, maintenance or use of a particular "designated premises."

Features

Pharmaceutical Companies, Off-Label Promotion And Qui Tam Actions Image

Pharmaceutical Companies, Off-Label Promotion And Qui Tam Actions

Randall L. Christian, Jason H.Casell & Francisco T. Rivas

In pharmaceutical actions, most false claims <i>qui tam</i> actions brought by whistleblowers involve off-label promotion, kickbacks, pricing allegations, and reimbursement abuses. Although these start out as civil lawsuits, they often end with the DOJ pressing charges against the pharmaceuticals manufacturer.

Features

Attorneys and Whistleblowing Image

Attorneys and Whistleblowing

Howard W. Goldstein

A recent opinion from the Southern District of New York indicates that lawyers will typically be prohibited from bringing <i>qui tam</i> actions against their former clients. And the new Dodd-Frank regulations expressly limit when an attorney can reap a whistleblower reward.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Strategy vs. Tactics: Two Sides of a Difficult Coin
    With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
    Read More ›
  • The Article 8 Opt In
    The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
    Read More ›
  • The Anti-Assignment Override Provisions
    UCC Sections 9406(d) and 9408(a) are one of the most powerful, yet least understood, sections of the Uniform Commercial Code. On their face, they appear to override anti-assignment provisions in agreements that would limit the grant of a security interest. But do these sections really work?
    Read More ›